GNH USA

Europe — EMA

Morfina Labesfal (Morphine Hydrochloride Trihydrate)

GNH USA supplies Morfina Labesfal (Morphine), a opioid analgesic for moderate to severe acute, post‑operative and cancer‑related pain.

Morphine Hydrochloride Trihydrate

Request sourcing

1
Pack/s

What is Morphine Hydrochloride Trihydrate?

Morphine Hydrochloride Trihydrate, the active ingredient in Morfina Labesfal, is an opioid analgesic presented as an injection solution for intramuscular, intravenous, subcutaneous use. It treats moderate to severe acute pain, post‑operative pain and cancer‑related pain in adult patients.

GNH USA supplies Morfina Labesfal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Morphine Hydrochloride Trihydrate used for?

Morphine, an opioid analgesic, is used for pain management in several clinical settings.

- Moderate to severe acute pain: provides rapid analgesia for short‑term severe pain episodes. - Post‑operative pain: reduces pain after surgical procedures to facilitate recovery. - Cancer‑related pain: helps control persistent pain associated with malignant disease.

What are the side effects of Morphine Hydrochloride Trihydrate?

Morphine may cause a range of adverse reactions, varying from frequent to rare but serious.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements. - Drowsiness: increased sleepiness or fatigue. - Itching: mild skin pruritus. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe respiratory depression: marked reduction in breathing that can be life‑threatening. - Hypotension: significant drop in blood pressure. - Allergic reactions: hives, swelling, or anaphylaxis.

What precautions apply to Morphine Hydrochloride Trihydrate?

When using Morfina Labesfal, clinicians should consider several safety measures.

- Dose titration: adjust dose to individual response and tolerance. - Renal impairment: use with caution and monitor for accumulation. - Hepatic impairment: consider reduced dosing and close observation. - Concomitant CNS depressants: increased risk of respiratory depression. - Pregnancy: category C; weigh benefits against potential fetal risk. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

What does Morphine Hydrochloride Trihydrate interact with?

Morphine interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Other opioids: additive respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates): heightened sedation and breathing suppression. - MAO inhibitors: risk of severe hypotension and serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin): may increase morphine plasma levels. - CYP3A4 inducers (e.g., rifampin): may reduce analgesic efficacy. - Diuretics: can enhance hypotensive effects.

Frequently asked questions

What is Morfina Labesfal used for?+
Morfina Labesfal is an injectable form of morphine hydrochloride used to manage moderate to severe acute pain, post‑operative pain, and cancer‑related pain. It provides rapid analgesia when administered intravenously, intramuscularly, or subcutaneously, helping patients achieve better comfort during short‑term or chronic painful conditions.
How does morphine work?+
Morphine works by binding to mu‑opioid receptors in the brain, spinal cord and peripheral nervous system. This binding inhibits the release of pain‑transmitting neurotransmitters, reduces neuronal excitability, and raises the threshold for pain perception, resulting in effective analgesia while also producing sedation and respiratory effects.
What is the usual dose of Morfina Labesfal?+
The specific dose of Morfina Labesfal is determined by the prescribing clinician based on the patient’s age, weight, pain severity, prior opioid exposure, and clinical setting. Healthcare professionals calculate the appropriate amount and frequency to achieve adequate pain control while minimizing adverse effects.
Is Morfina Labesfal safe in pregnancy or breastfeeding?+
Morphine is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out. It should only be used during pregnancy when the potential benefit justifies the potential risk. Morphine passes into breast milk; therefore, breastfeeding mothers should discuss alternatives with their healthcare provider.
How do I order Morfina Labesfal from GNH USA?+
To order Morfina Labesfal, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.
How does Morfina Labesfal compare with other opioid analgesics?+
Morfina Labesfal (morphine) is a benchmark opioid with well‑established efficacy for severe pain. Compared with synthetic opioids such as fentanyl, morphine has a longer history of use, a broader therapeutic window, and is less lipid‑soluble, which influences onset and duration. Choice of agent depends on pain type, required speed of onset, and patient‑specific factors.
What are the storage and handling requirements for Morfina Labesfal?+
Morfina Labesfal should be stored refrigerated at 2‑8 °C, protected from light, and kept in its original packaging. Do not freeze or shake the vial. Before use, allow the solution to reach room temperature if required, and inspect for particulate matter or discoloration.
How is Morfina Labesfal administered?+
Morfina Labesfal is supplied as a sterile injection solution and can be given intravenously, intramuscularly, or subcutaneously. The route, volume and rate of administration are determined by the prescribing clinician, who may use a syringe, infusion pump or other approved device according to standard aseptic techniques.
What are the most serious risks associated with Morfina Labesfal?+
The most serious risks include severe respiratory depression, profound hypotension, and the potential for dependence or addiction. Patients should be closely monitored for signs of breathing difficulty, low blood pressure, and unusual sedation, especially when initiating therapy or when combined with other central nervous system depressants.
Who should not use Morfina Labesfal?+
Morfina Labesfal is contraindicated in individuals with known hypersensitivity to morphine or any component of the formulation, in patients with severe respiratory depression, acute asthma attacks, or paralytic ileus. Caution is also advised for patients with uncontrolled head injury or increased intracranial pressure.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Morphine Hydrochloride Trihydrate
Route
Intramuscular Use , Intravenous Use , Subcutaneous
Manufacturer
Labesfal Laboratorios Almiro, S.A.
Origin
EU

Related products

Compensan Retard

Compensan Retard

Morphine Hydrochloride Trihydrate

G.L. Pharma Gmbh
EU
Depolan

Depolan

Morphine Hydrochloride Trihydrate

G.L. Pharma Gmbh
EU
Depolan

Depolan

Morphine Hydrochloride Trihydrate

G.L. Pharma Gmbh
EU
Lacedor

Lacedor

Morphine Hydrochloride Trihydrate

Kalceks
EU